ISTH guidelines for antithrombotic treatment in COVID-19 : Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine
Dagsetning
Höfundar
Journal Title
Journal ISSN
Volume Title
Útgefandi
Útdráttur
The Clinical Practice Committee of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorses the ISTH guidelines for antithrombotic treatment in COVID-19. This evidence-based guideline serves as a useful decision aid for Nordic anaesthesiologists caring for patients with COVID-19.
Lýsing
Publisher Copyright: © 2023 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley & Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation. Funding Information: Funding was provided from the Scandinavian Society of Anaesthesiology and Intensive Care Medicine and institutional and/or departmental sources. The Clinical Practice Committee (CPC) of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine (SSAI) assessed the 2022 ISTH guidelines for antithrombotic treatment in COVID-197 for possible endorsement. The Appraisal of Guidelines for REsearch and Evaluation (AGREE) II tool8 was used. Details on the endorsement process are available elsewhere.9 Publisher Copyright: © 2023 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley & Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation.
Efnisorð
AGREE II, anticoagulation, clinical practice guideline, COVID-19, ISTH, thromboprophylaxis, Anesthesiology and Pain Medicine, SDG 3 - Good Health and Well-being
Citation
Chew, M S, Olkkola, K T, Kalliomäki, M L, Rehn, M, Sigurðsson, M I & Møller, M H 2023, 'ISTH guidelines for antithrombotic treatment in COVID-19 : Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine', Acta Anaesthesiologica Scandinavica, vol. 67, no. 8, pp. 1118-1120. https://doi.org/10.1111/aas.14259